Literature DB >> 8189545

Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1.

T Middleton1, B Sugden.   

Abstract

The capacity to bind the Epstein-Barr viral protein EBNA1 increases the retention of the plasmid in dividing cells. This retention requires binding of multiple EBNA1 molecules for function, although significant retention activity is seen with fewer EBNA1 binding sites than are required to activate replication or transcription. The regions of EBNA1 that are required for increased plasmid retention overlap with those required for activation of transcription and replication. The similarities in traits of EBNA1 that are required for support of DNA replication and retention of plasmid DNA indicate that both may be mediated by interactions with an overlapping set of cellular proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189545      PMCID: PMC236919     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Epstein-Barr virus DNA is amplified in transformed lymphocytes.

Authors:  B Sugden; M Phelps; J Domoradzki
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.

Authors:  T A Gahn; C L Schildkraut
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.

Authors:  D A Wysokenski; J L Yates
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Isolation of human sequences that replicate autonomously in human cells.

Authors:  P J Krysan; S B Haase; M P Calos
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  Replication of latent Epstein-Barr virus genomes in Raji cells.

Authors:  A Adams
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines.

Authors:  A Harris; B D Young; B E Griffin
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

7.  A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.

Authors:  D Reisman; J Yates; B Sugden
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

8.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

9.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

10.  Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.

Authors:  E A Grogan; W P Summers; S Dowling; D Shedd; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more
  45 in total

1.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  The linking regions of EBNA1 are essential for its support of replication and transcription.

Authors:  D Mackey; B Sugden
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.

Authors:  E R Leight; B Sugden; E R Light
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.

Authors:  E R Leight; B Sugden
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 5.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  John Sears; John Kolman; Geoffrey M Wahl; Ashok Aiyar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Essential elements of a licensed, mammalian plasmid origin of DNA synthesis.

Authors:  Jindong Wang; Scott E Lindner; Elizabeth R Leight; Bill Sugden
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

8.  Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.

Authors:  Theresa L Hodin; Tanbir Najrana; John L Yates
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

9.  Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.

Authors:  Chunghun Lim; Hekwang Sohn; Daeyoup Lee; Yousang Gwack; Joonho Choe
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.

Authors:  A Aiyar; C Tyree; B Sugden
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.